XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Condensed Consolidated Statements of Operations [Abstract]        
Net sales $ 171,862,000 $ 151,819,000 $ 528,206,000 $ 488,347,000
Cost of goods sold 141,819,000 130,826,000 430,448,000 410,536,000
Gross profit 30,043,000 20,993,000 97,758,000 77,811,000
Operating expenses:        
General and administrative 15,198,000 13,599,000 42,125,000 42,079,000
Sales and marketing 5,931,000 5,634,000 17,038,000 17,242,000
Research and development 2,539,000 2,547,000 7,352,000 8,330,000
Foreign exchange impact of lease liabilities and forward contracts (3,149,000) (4,313,000) (2,659,000) (2,553,000)
Total operating expenses 20,519,000 17,467,000 63,856,000 65,098,000
Operating income 9,524,000 3,526,000 33,902,000 12,713,000
Other expenses:        
Interest expense, net 18,297,000 11,471,000 45,400,000 27,675,000
Change in fair value of compound net derivative liability 1,160,000 0 1,690,000 0
Loss on extinguishment of debt 0 0 168,000 0
Total other expenses 19,457,000 11,471,000 47,258,000 27,675,000
Loss before income tax expense (benefit) (9,933,000) (7,945,000) (13,356,000) (14,962,000)
Income tax expense (benefit) 37,281,000 (8,971,000) 37,226,000 (9,296,000)
Net (loss) income $ (47,214,000) $ 1,026,000 $ (50,582,000) $ (5,666,000)
Basic net (loss) income per share (in dollars per share) $ (2.4) $ 0.05 $ (2.58) $ (0.29)
Diluted net (loss) income per share (in dollars per share) $ (2.4) $ 0.05 $ (2.58) $ (0.29)
Weighted average number of shares outstanding:        
Basic (in shares) 19,634,306 19,474,871 19,580,960 19,383,531
Diluted (in shares) 19,634,306 19,634,153 19,580,960 19,383,531